Respiratory illness levels in the U.S. have declined so much in recent weeks that they are approaching numbers usually seen during non-flu season.
“This flu season started really early because there were so many children with zero experience with flu, common colds, and RSV,” David Celentano, ScD, chair of epidemiology at Johns Hopkins Bloomberg School of Public Health, toldData is now pointing to what may amount to simply an early peak for flu and RSV. About 25 million people in the U.S. have had the flu this year and 17,000 people have died of it.
The once record-setting hospitalization rate for the flu has fizzled so much that this season may finish up below average for hospitalizations, the CDC projected. The agency said this year’s flu vaccine has been very effective against circulating strains. COVID-19 metrics are also trending steeply downward, with some western parts of the U.S. reporting “some of their lowest-ever case and hospitalization rates,”Despite fewer COVID-19 cases and hospitalizations nationwide, the virus remains deadly, with most January days seeing more than 500 deaths each.predicted that the XBB.1.5 variant would be circulating nationally above 50% for the first time this week.
Ireland Latest News, Ireland Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Managing Respiratory Symptoms in the 'Tripledemic' EraReaders weighed in on Dr Charles Vega's approach to a patient whose symptoms could be from COVID-19, flu, or RSV. Tripledemic
Read more »
Recent snowfalls may slow water level decline at Lake MeadWeather officials say hefty snowfalls that fed the Colorado River in recent weeks may slow the water level decline of Lake Mead on the Nevada-Arizona border.
Read more »
Recent snowfalls may slow water level decline at Lake MeadWhile this wet winter likely won't solve the water issues the southwestern U.S. faces, it at least may provide some relief for the rapidly dropping water levels at Lake Powell and Lake Mead. abc15
Read more »
Moderna’s RSV vaccine gets Breakthrough Therapy statusModerna Inc. said Monday that the Food and Drug Administration granted the company’s experimental respiratory syncytial virus vaccine a Breakthrough Therapy...
Read more »
FDA grants expedited review for Moderna RSV vaccine for 60 and olderModerna announced Monday that its vaccine against respiratory syncytial virus, or RSV, for adults 60 years and older has been granted breakthrough designation from the Food and Drug Administration.
Read more »